Drugs / bacillus Calmette-Guérin
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT00002990 | Mar 1997 → Apr 2005 | urinary bladder cancer | European Organisation for Research and Treatment of Cancer - EORTC | Completed | Missed primary |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | bacillus Calmette-Guérin | “maintenance bacillus Calmette-Guérin (BCG)” PMID 26210894 ↗ Jul 2015 |
| Known as | BCG | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00002990 ↗ |
| Modality | Vaccine | “Bacillus Calmette-Guerin (BCG) vaccine” NCT00002990 ↗ |
| Route | Other | “Intravesical BCG” NCT00002990 ↗ |